A $4.75m grant will support the development of EIS-12656, which is being studied alone and in combination with PARP ...
Investment advisers, the gatekeepers to retail and high-net-worth capital, are seen overtaking hedge fund managers in owning ...
The United States briefly overtook Saudi Arabia as the world’s top oil exporter for the first time this year, cementing its status as one of the world’s most important energy producers. US to ...
In what Schomburg terms a “’winner takes all’ market”, Eisbach believe their candidate can supplant PARP inhibitors as a less toxic option. Following IND approval in May 2024, EIS-12656 is ...
AstraZeneca has thrown down the gauntlet to AbbVie and Johnson & Johnson with new data for Calquence in chronic lymphocytic leukaemia (CLL) that it says show a safety advantage over Imbruvica ...